AIMCA
HBIO icon

Alberta Investment Management Corp (AIMCo)’s Harvard Bioscience HBIO Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,139
Closed -$71K – 1303
2022
Q1 		$71K Hold
1,139
– – ﹤0.01% 1250
2021
Q4 		$80K Buy
+1,139
New +$81K ﹤0.01% 960

Other funds holding HBIO

HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s HBIO Position: Q2 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Harvard Bioscience (HBIO) in Q2 2022, closing a stake of 1,139 shares — an estimated $71K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HBIO in Q4 2021 and held it in 2 quarters. The position peaked at $80K in Q4 2021. 90 funds tracked by Wall St. Rank hold HBIO as of Q2 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Harvard Bioscience position as of Q2 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 1,139 Harvard Bioscience shares in Q2 2022, an estimated $71K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Harvard Bioscience in Q4 2021 and held it in 2 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Harvard Bioscience position peaked at $80K in Q4 2021.
  • 90 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q2 2022, filed 15 Aug 2022.